Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$405M |
| 2 |
Gilead Sciences
GILD
|
+$314M |
| 3 |
Union Pacific
UNP
|
+$229M |
| 4 |
Intel
INTC
|
+$224M |
| 5 |
Meta Platforms (Facebook)
META
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$342M |
| 2 |
SWY
SAFEWAY INC
SWY
|
+$210M |
| 3 |
TSMC
TSM
|
+$174M |
| 4 |
GSK
GSK
|
+$156M |
| 5 |
Johnson & Johnson
JNJ
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.05% |
| 2 | Technology | 11.94% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Staples | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
101
DELISTED
PDL BioPharma, Inc.
PDLI
| $84.2M | 0.18% |
11,971,554
+200,554
| +2% | +$1.45M |
|
102
Teva Pharmaceuticals
TEVA
$36.2B
| $83.4M | 0.18% |
1,338,963
+374,300
| +39% | +$21.8M |
|
|
MIC
103
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $83.4M | 0.18% |
1,012,900
-426,400
| -30% | -$32.4M |
|
|
BRCM
104
DELISTED
BROADCOM CORP CL-A
BRCM
| $83M | 0.18% |
1,917,657
+153,200
| +9% | +$6.68M |
|
105
TechnipFMC
FTI
$29.9B
| $81.8M | 0.17% |
2,970,778
+2,849,684
| +2,353% | +$83.5M |
|
106
Intercontinental Exchange
ICE
$84.1B
| $81.1M | 0.17% |
+1,738,990
| New | +$78.4M |
|
|
WNR
107
DELISTED
Western Refining Inc
WNR
| $80.9M | 0.17% |
1,637,100
+1,300,600
| +387% | +$54.3M |
|
|
GGP
108
DELISTED
GGP Inc.
GGP
| $80.8M | 0.17% |
2,732,700
+2,177,000
| +392% | +$65M |
|
109
Charter Communications
CHTR
$15.7B
| $79M | 0.17% |
408,900
+175,500
| +75% | +$30.4M |
|
|
ESRX
110
DELISTED
Express Scripts Holding Company
ESRX
| $78.8M | 0.17% |
908,139
+562,900
| +163% | +$47.2M |
|
|
BRFS
111
DELISTED
BRF SA
BRFS
| $77.8M | 0.17% |
3,932,960
+1,509,200
| +62% | +$33.5M |
|
|
LNKD
112
DELISTED
LinkedIn Corporation
LNKD
| $77M | 0.16% |
308,300
+15,000
| +5% | +$3.72M |
|
113
United Therapeutics
UTHR
$26.3B
| $77M | 0.16% |
446,500
+261,262
| +141% | +$39.8M |
|
114
Euronet Worldwide
EEFT
$3.01B
| $76.6M | 0.16% |
1,304,045
+205,800
| +19% | +$10.9M |
|
|
WOOF
115
DELISTED
VCA Inc.
WOOF
| $76.2M | 0.16% |
1,389,200
-190,900
| -12% | -$9.98M |
|
116
Regeneron Pharmaceuticals
REGN
$69.9B
| $75.6M | 0.16% |
+167,488
| New | +$71M |
|
|
MGLN
117
DELISTED
Magellan Health Services, Inc.
MGLN
| $73.7M | 0.16% |
1,040,244
-126,655
| -11% | -$7.97M |
|
118
Bank of America
BAC
$436B
| $73.6M | 0.16% |
4,782,866
-6,668,300
| -58% | -$107M |
|
119
Ecolab
ECL
$76.4B
| $73M | 0.16% |
638,322
+227,300
| +55% | +$24.9M |
|
120
Starbucks
SBUX
$118B
| $72.2M | 0.15% |
1,525,784
-1,023,908
| -40% | -$46M |
|
121
TFS Financial
TFSL
$5.07B
| $72.1M | 0.15% |
4,911,955
+157,542
| +3% | +$2.26M |
|
|
AZPN
122
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $72.1M | 0.15% |
1,872,600
-18,200
| -1% | -$701K |
|
|
ETP
123
DELISTED
Energy Transfer Partners L.p.
ETP
| $71.1M | 0.15% |
1,275,213
+1,227,249
| +2,559% | +$72.8M |
|
124
Verisk Analytics
VRSK
$27.1B
| $70.7M | 0.15% |
990,200
-219,366
| -18% | -$14.8M |
|
125
Sony
SONY
$131B
| $70.3M | 0.15% |
13,126,000
+8,908,000
| +211% | +$45M |
|
Similar funds
Renaissance Technologies's Q1 2015 Portfolio in Review
As of Q1 2015, Renaissance Technologies held 3,575 positions worth $47B, up 13% from $41.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Renaissance Technologies deployed $4.23B of net new capital in Q1 2015, opening 633 new positions and adding to 1,637 existing holdings. Its largest new stake was Amazon: 23,057,100 shares worth $429M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was McDonald's, an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2015 buy was Amazon: 23,057,100 shares worth $429M.
- Renaissance Technologies added most to Gilead Sciences in Q1 2015, an estimated $314M increase.
- Renaissance Technologies's biggest Q1 2015 reduction was McDonald's, cutting an estimated $342M.
- Renaissance Technologies fully exited SAFEWAY INC in Q1 2015, selling an estimated $210M.
- Renaissance Technologies's ten largest holdings make up 9.9% of its $47B portfolio in Q1 2015.
- Renaissance Technologies opened 633 new positions and closed 438 in Q1 2015.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $47B.
Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.